Annovis Bio, Inc.
General ticker "ANVS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $30.8M (TTM average)
Annovis Bio, Inc. follows the US Stock Market performance with the rate: 41.8%.
Estimated limits based on current volatility of 3.9%: low 2.48$, high 2.68$
Factors to consider:
- Earnings expected soon, date: 2026-03-20 bmo
- Total employees count: 6 (+20.0%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Economic downturns and volatility, Third-party risks, Cybersecurity threats, Labor/talent shortage/retention
Short-term ANVS quotes
Long-term ANVS plot
Financial data not available